106 related articles for article (PubMed ID: 10396075)
21. Plasmacytoma-refractory BALB/cAnPt mice have naive T cell and highly specific B cell responses to antigen.
McDonald AH; Byrd LG; Mainhart CR; Sopher J; Smith-Gill SJ
Mol Immunol; 1996 Oct; 33(15):1183-96. PubMed ID: 9070667
[TBL] [Abstract][Full Text] [Related]
22. Induction of plasma cell tumours with 2,6,10,14-tetramethylpentadecane (pristane) and paraffin oil (paraffinum perliquidum) in BALB/c mice simultaneously exposed to sustained antigenic stimulation with bovine serum albumin (BSA).
Janz S; Püschel W; Raabe F; Storch H
Arch Geschwulstforsch; 1987; 57(1):25-30. PubMed ID: 3566462
[TBL] [Abstract][Full Text] [Related]
23. BALB/c.CBA/N mice carrying the defective Btk(xid) gene are resistant to pristane-induced plasmacytomagenesis.
Potter M; Wax JS; Hansen CT; Kenny JJ
Int Immunol; 1999 Jul; 11(7):1059-64. PubMed ID: 10383938
[TBL] [Abstract][Full Text] [Related]
24. Elevation of interleukin-6 in response to a chronic inflammatory stimulus in mice: inhibition by indomethacin.
Shacter E; Arzadon GK; Williams J
Blood; 1992 Jul; 80(1):194-202. PubMed ID: 1611085
[TBL] [Abstract][Full Text] [Related]
25. Increased susceptibility of old mice to plasmacytoma induction.
Sato K; Bloom ET; Hirokawa K; Makinodan T
J Gerontol; 1986 Jan; 41(1):24-9. PubMed ID: 3484487
[TBL] [Abstract][Full Text] [Related]
26. The reaction of pristane (2,6,10,14-tetramethylpentadecane) with radiolytically generated reactive oxygen intermediates results in a stable genotoxic compound as assessed by the SOS chromotest.
Janz S; Brede O; Müller J
Carcinogenesis; 1991 Jul; 12(7):1241-6. PubMed ID: 2070489
[TBL] [Abstract][Full Text] [Related]
27. Fusion between enveloped viruses and erythrocyte membranes is induced by the isoprenoid alkane pristane (2,6,10,14-tetramethylpentadecane).
Janz S; Shacter E; Herrmann A
Cancer Biochem Biophys; 1994 Apr; 14(1):1-14. PubMed ID: 7796384
[TBL] [Abstract][Full Text] [Related]
28. v-abl does not abolish IL-6 requirement by murine plasmacytoma cells.
Sugiyama H; Wiener F; Babonits M; Silva S; Hirano T; Kishimoto T; Klein G
Int J Cancer; 1991 May; 48(2):234-8. PubMed ID: 2019468
[TBL] [Abstract][Full Text] [Related]
29. Gas chromatographic-mass spectrometric investigation of four commercial pristane (2.6.10.14-tetramethylpentadecane) preparations used for plasmacytoma induction in BALB/c mice.
Janz S; Birkenfeld T; Herzschuh R; Storch H
Arch Geschwulstforsch; 1989; 59(6):415-22. PubMed ID: 2596957
[TBL] [Abstract][Full Text] [Related]
30. Detection of immunoglobulin/c-myc recombinations in mice that are resistant to plasmacytoma induction.
Müller JR; Jones GM; Potter M; Janz S
Cancer Res; 1996 Jan; 56(2):419-23. PubMed ID: 8542601
[TBL] [Abstract][Full Text] [Related]
31. Specific pathogen-free BALB/cAn mice are refractory to plasmacytoma induction by pristane.
Byrd LG; McDonald AH; Gold LG; Potter M
J Immunol; 1991 Nov; 147(10):3632-7. PubMed ID: 1682379
[TBL] [Abstract][Full Text] [Related]
32. Genotoxicity assessment of the plasmacytomagenic agent pristane (2.6.10.14-tetramethylpentadecane) and four related alkanes by the SOS chromotest.
Janz S; Huttunen T; Herzschuh R; Storch H
Arch Geschwulstforsch; 1988; 58(2):73-8. PubMed ID: 3288166
[TBL] [Abstract][Full Text] [Related]
33. Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus.
Satoh M; Weintraub JP; Yoshida H; Shaheen VM; Richards HB; Shaw M; Reeves WH
J Immunol; 2000 Jul; 165(2):1036-43. PubMed ID: 10878381
[TBL] [Abstract][Full Text] [Related]
34. Differential susceptibility of BALB/c and DBA/2 cells to plasmacytoma induction in reciprocal chimeras.
Silva S; Sugiyama H; Babonits M; Wiener F; Klein G
Int J Cancer; 1991 Sep; 49(2):224-8. PubMed ID: 1879968
[TBL] [Abstract][Full Text] [Related]
35. Transplantation of primary plasma cell tumor without 2,6,10,14- tetramethylpentadecane (pristane) treatment of the hosts.
Platica M; Bojko C; Hollander VP
Cancer Res; 1980 Mar; 40(3):579-81. PubMed ID: 7471077
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the growth characteristics of a primary BALB/c IgG plasmacytoma.
Hentschel R; Kölsch E
Int J Cancer; 1983 Jun; 31(6):749-56. PubMed ID: 6862684
[TBL] [Abstract][Full Text] [Related]
37. Generation of immunoglobulin/c-myc recombinations in murine Peyer's patch follicles.
Müller JR; Mushinski EB; Jones GM; Williams JA; Janz S; Hausner PF; Potter M
Curr Top Microbiol Immunol; 1997; 224():251-5. PubMed ID: 9308248
[No Abstract] [Full Text] [Related]
38. Experimental plasmacytomas in relation to human multiple myeloma.
Azar HA
Ann Clin Lab Sci; 1974; 4(3):157-63. PubMed ID: 4825619
[No Abstract] [Full Text] [Related]
39. The accelerating role of Abelson murine leukemia virus in murine plasmacytoma development: in vitro infection of spleen cells generates donor-type tumors after transfer to pristane-treated BALB/c mice.
Sugiyama H; Weber G; Silva S; Babonits M; Wiener F; Klein G
Int J Cancer; 1989 Aug; 44(2):348-52. PubMed ID: 2547729
[TBL] [Abstract][Full Text] [Related]
40. Specific chromosome translocation in pristane-induced plasmacytomas of NZB mice.
Oikawa T; Kuzumaki N; Yamada T
J Natl Cancer Inst; 1984 Feb; 72(2):347-53. PubMed ID: 6582321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
